Promega

ViaFect™ Transfection Reagent

#H1299

100
Citing papers
41.6k
Combined citations
Supplier page Find this product

Research areas

Cancer-related Molecular Pathways28Epigenetics and DNA Methylation16RNA modifications and cancer15MicroRNA in disease regulation14Ubiquitin and proteasome pathways13Circular RNAs in diseases12Cancer-related molecular mechanisms research11Cancer Research and Treatments8

Papers citing this product

1
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
The EMBO Journal·2004·2.7k cit.·DOI
2
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Nature·2021·1.4k cit.·DOI
3
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Cell·2020·1.2k cit.·DOI
4
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Nature·2022·1.2k cit.·DOI
5
The tumor suppressor microRNA <i>let-7</i> represses the HMGA2 oncogene
Genes & Development·2007·1.2k cit.·DOI
6
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Nature Communications·2020·1.1k cit.·DOI
7
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
PLoS Medicine·2006·1k cit.·DOI
8
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Nature Communications·2014·986 cit.·DOI
9
The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer
Cancer Discovery·2014·842 cit.·DOI
10
p53 isoforms can regulate p53 transcriptional activity
Genes & Development·2005·802 cit.·DOI

Similar products

ProductVendorPricePapers
ViaFect™ Transfection ReagentPromega—100
ViaFect™ Transfection ReagentPromega—100
ViaFect™ Transfection ReagentPromega—13
ViaFect™ Transfection Reagent — Evidence — PubIndex